Advancement of Astragali Radix in anti-tumor:Active components and combination therapyOA
Advancement of Astragali Radix in anti-tumor:Active components and combination therapy
Jiaxin Jiang;Min Li;Qiwen Lu;Gongjian Dai;Qichen Zhan;Jing Chen;Xuan Han
School of Integrative Medicine,Nanjing University of Chinese Medicine,Nanjing 210023,ChinaDepartment of Oncology,Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine,Nanjing 210022,ChinaSchool of Integrative Medicine,Nanjing University of Chinese Medicine,Nanjing 210023,ChinaDepartment of Colorectal Surgery,Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine,Nanjing 210001,ChinaSchool of Pharmacy,Nanjing University of Chinese Medicine,Nanjing 210023,ChinaNational Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture,Nanjing University of Chinese Medicine,Nanjing 210023,ChinaSchool of Integrative Medicine,Nanjing University of Chinese Medicine,Nanjing 210023,China
anti-neoplasticanti-VEGFAstragali RadixferroptosisimmunomodulationPDK1/AKTPI3K/AKT/mTORTLR4/NF-κB
anti-neoplasticanti-VEGFAstragali RadixferroptosisimmunomodulationPDK1/AKTPI3K/AKT/mTORTLR4/NF-κB
《中草药（英文版）》 2026 (2)
312-328,17
The authors would like to extend their sincere gratitude to the funding organizations for their financial support.This work was supported by the National Natural Science Foundation of China[Grant No.82204696]the Foundation of the National Natural Science Foundation of China[Grant No.82305052]the Natural Science Foundation project of Nanjing University of Chinese Med-icine[Grant No.XPT82204696]and Jiangsu Province University Innovation Training Program[Grant No.202410315155Y].We are also deeply thankful to all the authors for their valuable contri-butions and collaborative efforts in the preparation of this review.
评论